High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemia.
暂无分享,去创建一个
M. Hallek | M. Keating | M. Herling | N. Weit | Dan Jones | K. Patel | Nils Lilienthal | Kaushali A. Patel
暂无分享,去创建一个
M. Hallek | M. Keating | M. Herling | N. Weit | Dan Jones | K. Patel | Nils Lilienthal | Kaushali A. Patel